肌萎缩侧索硬化认知与运动亚组的进行性神经化学异常:前瞻性多中心研究
结果显示ALS患者基线运动皮层NAA比值降低,快速进展和高上运动神经元负荷者下降更明显且随时间进展,前额叶NAA比值仅在认知障碍患者中降低。
要点
- ALS患者运动皮层NAA比值在基线即降低,且与疾病进展速度和上运动神经元体征严重程度相关。
- 快速进展和高上运动神经元负荷亚组的运动皮层NAA比值随时间显著下降。
- 前额叶皮层NAA比值降低仅见于认知障碍ALS患者,且不随时间变化。
核心结论
- ALS中运动皮层的进行性退变与更侵袭性的临床表现相关,为疾病异质性提供了空间和时间上可变脑退变的生物学证据。
- 标准化影像协议可能有助于临床试验中的患者选择或亚组划分。
研究设计与样本
- 参与者在基线以及第4个月和第8个月接受系列临床评估和磁共振波谱检查,采用5个中心统一的协议。
- 在运动皮层和前额叶皮层定量NAA比值,并根据疾病进展速率、上运动神经元体征和认知状态对患者进行亚组分层。
- 使用线性混合模型进行NAA代谢物比值的基线和纵向比较。
主要发现
- ALS患者基线运动皮层NAA比值降低(p < 0.001)。
- 疾病进展更快速和上运动神经元体征更严重的患者运动皮层NAA比值更低(p < 0.05)。
- 快速进展组(p < 0.01)和高上运动神经元负荷组(p < 0.01)的运动皮层NAA比值随时间下降。
- 上运动神经元体征的严重程度随时间无显著变化。
- 前额叶皮层NAA比值仅在认知障碍患者中降低(p < 0.05),且前额叶皮层代谢物不随时间变化。
关键数值与推荐
- 运动皮层NAA比值与更快的疾病进展和更严重的上运动神经元体征相关(Class II证据)。
临床怎么用
- 磁共振波谱检测的运动皮层NAA比值可能作为ALS疾病进展速度和上运动神经元负荷的生物标志物。
- 标准化影像协议可能用于临床试验中的患者选择或亚组划分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate progressive cerebral degeneration in amyotrophic lateral sclerosis (ALS) by assessing alterations in N-acetylaspartate (NAA) ratios in the motor and prefrontal cortex within clinical subgroups of ALS. METHODS: Seventy-six patients with ALS and 59 healthy controls were enrolled in a prospective, longitudinal, multicenter study in the Canadian ALS Neuroimaging Consortium. Participants underwent serial clinical evaluations and magnetic resonance spectroscopy at baseline and 4 and 8 months using a harmonized protocol across 5 centers. NAA ratios were quantified in the motor cortex and prefrontal cortex. Patients were stratified into subgroups based on disease progression rate, upper motor neuron (UMN) signs, and cognitive status. Linear mixed models were used for baseline and longitudinal comparisons of NAA metabolite ratios. RESULTS: Patients with ALS had reduced NAA ratios in the motor cortex at baseline (p < 0.001). Ratios were lower in those with more rapid disease progression and greater UMN signs (p < 0.05). A longitudinal decline in NAA ratios was observed in the motor cortex in the rapidly progressing (p < 0.01) and high UMN burden (p < 0.01) cohorts. The severity of UMN signs did not change significantly over time. NAA ratios were reduced in the prefrontal cortex only in cognitively impaired patients (p < 0.05); prefrontal cortex metabolites did not change over time. CONCLUSIONS: Progressive degeneration of the motor cortex in ALS is associated with more aggressive clinical presentations. These findings provide biological evidence of variable spatial and temporal cerebral degeneration linked to the disease heterogeneity of ALS. The use of standardized imaging protocols may have a role in clinical trials for patient selection or subgrouping. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that MRS NAA metabolite ratios of the motor cortex are associated with more rapid disease progression and greater UMN signs in patients with ALS. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov Identifier: NCT02405182.
引用
- Ta D, Ishaque A, Srivastava O, et al. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study. Neurology. 2021. PMID: 34426551. doi:10.1212/WNL.0000000000012367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。